Comparative study of the costs of diabetic foot in the developed countries;Couts de sante lies aux lesions du pied chez les diabetiques dans les pays developpes: Plaidoyer pour la creation de structures de soins adaptees

Diabetes and Metabolism

Volumn 26, Issue 1, 2000, Pages 75-80

  Carpentier, B ^b   Pradines, S ^b   Benhamou, P Y ^b   Halimi, S ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Amputations; Costs; Diabetes; Diabetic foot; Health economy; Healthcare network

Indexed keywords

AMPUTATION; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETIC FOOT; HEALTH CARE COST; HUMAN; OUTPATIENT CARE; PREVALENCE; REVIEW; ARTICLE; COST; DEVELOPED COUNTRY; ECONOMICS; NETHERLANDS; ORGANIZATION AND MANAGEMENT; PATIENT CARE; SWEDEN; UNITED KINGDOM; UNITED STATES;

COSTS AND COST ANALYSIS; DEVELOPED COUNTRIES; DIABETES MELLITUS; DIABETIC FOOT; GREAT BRITAIN; HUMANS; NETHERLANDS; PATIENT CARE TEAM; PREVALENCE; SWEDEN; UNITED STATES;

EID: 0034133943     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Detournay B, Vauzelle-Kervroedan F, Charles MA, et al. Epidémiologie, prise en charge et coût du diabète de type 2 en France en 1998. Diabetes Metab, 1999, 25, 356-365.
2. Kumar S, Ashe HA, Parnell LN, Fernando DJS, Tsigos C, Young RJ, Ward JD, Boulton AJM. The prevalence of foot ulceration and its correlates in type 2 diabetic patients : a population-based study. Diabet Med, 1994, 11, 480-484.
3. Larsson J, Apelqvist J. Toward less amputations in diabetic patients : incidence, causes, cost, treatment and prevention : a review. Acta Orthop Scand, 1995, 66, 181-192.
4. Reiber GE. Diabetic foot care. Financial implications and practical guidelines. Diabetes Care, 1992, 15, 29-31.
5. Ward JD. The cost of diabetic foot problems. Pharmaco-Economics, 1995, 8, 55-57.
6. Williams DDR. The size of the problem : epidemiological and economic aspects of foot problems in diabetes. In : Boulton AJM, Connor H, Cavanagh P eds, The foot in diabetes, ed 2 New York : 1994, p 15-24.
7. Smith D, Weinberger M, Katz B. A controlled trial to increase office visits and reduce hospitalisations of diabetic patients. J Gen Intern Med, 1987, 2, 232-238.
8. Raviola CA, Nichter LS, Baker D, Busuttil RW, Machleder HI, Moore WS. Cost of treating advanced leg ischemia : bypass graft versus primary amputation. Arch Surg, 1988, 123, 495-496.
9. Wright WE, Kaplan GA. Trends in lower extremity amputations : California, 1983-1987. California chronic and sentinel diseases ; Surveillance Program Ressource Document, Sacramento, California Departement Health Service 1989.
10. Leese B. The cost of diabete and its complications. Soc Sci Med, 1992, 35, 1303-1310.
11. Jönsson B, Persson V. Diabetes : a study in health economics ; Swedisch Institute for Health Economics, Meddelande, 1981.
12. Van Houtum WH, Lavery LA, Harkless LB. The cost of diabete related lower extremity amputations in the Netherland. Diabet Med, 1995, 12, 777-781.
13. Apelqvist J. Diabetic foot ulcers in a multidisciplinary setting : an economic analysis of primary healing and healing with amputation. J Intern Med, 1994, 235, 463-471.
14. Bouter KP, Storm AJ, De Groot RRM, Vitslager R, Erkelens DW, Diepersloot RJA. Diabetic foot in Dutch Hospitals : epidemiologica features and clinical outcomes. Eur J Med, 1993, 2, 215-218.
15. Currie CJ, Morgan CLL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy and ulceration in diabetes. Diabetes Care, 1998, 21, 42-48.
16. Edmonds ME, Blundell MP, Morris ME. Improved survival of the diabetic foot : the impact of the role of specialised foot clinics. Q J Med, 1986, 60, 763-771.
17. Assal JP, Mülhauser I, Pernet A, Gfeller R, Jörgens V, Berger M. Patient education as the basis for diabetic care in clinical practice. Diabetologia, 1985, 28, 602-613.
18. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting ; an economic analysis of primary healing and healing with amputation. J Intern Med, 1994, 235, 463-471.
19. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long term cost for foot ulcers in diabetic patients in a multidsciplinary setting. Foot Ankle Internat, 1995, 7, 388-394.
20. Halimi S, Benhamou PY, Charras H. Le coût du pied diabétique. Diabetes Metab, 1993, 19 (suppl 5), 518-522.
21. Mackey WC, Mc Collough JL, Conlon TP. The cost of surgery for limb threatening ischemia. Surgery, 1986, 99, 26-35.
22. Gupta SK, Veith FJ, Ascer E. Cost factors in limb treathening ischemia due to infrainguinal arteriosclerosis. Eur J Vasc Surg, 1988, 2, 151-154.
23. Connor H. The economic impact of diabetic foot disease in : Connor H., Boulton AJM., Ward JD. eds, The foot in diabetes New York, Wiley and Son Ltd, 1987, 145-149.
24. Gibbons GW, Marcaccio EJ, Burgess AW, Pomposelli FB, Freeman DV, Campbell DR, Miller A, Logerfo FW. Improved quality of diabete foot care : 1984 vs 1990 ; reduced lengh of stay and costs, insufficient reimbursement. Arch Surg, 1993, 128, 576-581.
25. Panayiotopoulos YP, Tyrrell MR, Arnold FJL, Korzon-Burakowska A, Amiel SA. Results and cost analysis of distal (crural-pedal) arterial revascularisation for limb salvage in diabetic and non diabetic patients. Diabet Med, 1997, 14, 214-220.
26. Van Houtum WH, Lavery LA. Outcomes associated with diabetes related amputations in the Netherlands and in the state of California, USA. J Intern Med, 1996, 240, 227-231.
27. Triomphe A. The socioeconomic cost of diabetic complications in France. Diabet Med, 1991, 8, S-30-32.
28. Morrison WB, Schweitzer ME, Wapner KL, Hecht PJ, Gannon FH, Behm WR. Osteomyelitis in feet of diabetics : clinical accuracy, surgical utility and cost effectiveness of MR Imaging. Radiology, 1995, 196, 557-564.
29. Weinstein D, Wang A, Chambers R, Stewart CA, Motz HA. Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Foot Ankle Int, 1993, 14, 18-22.
30. Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan L, Dukes K, Pauker SG. Foot infections in diabetic patients : decision and cost-effectiveness analysis. JAMA, 1995, 273, 712-720.
31. West NJ. Systemic antimicrobial treatment of foot infections in diabetic patients. Am J Health Syst Pharm, 1995, 52, 1199-1207.
32. Assal JP. Cost-effectiveness of diabetes education. Pharmaco economics, 1995, 8 (suppl I), 68-71.